Xiaoyan Chen

5.5k total citations
222 papers, 4.4k citations indexed

About

Xiaoyan Chen is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Xiaoyan Chen has authored 222 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 48 papers in Oncology and 46 papers in Pharmacology. Recurrent topics in Xiaoyan Chen's work include Pharmacogenetics and Drug Metabolism (34 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Analytical Methods in Pharmaceuticals (22 papers). Xiaoyan Chen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (34 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Analytical Methods in Pharmaceuticals (22 papers). Xiaoyan Chen collaborates with scholars based in China, United States and Hong Kong. Xiaoyan Chen's co-authors include Dafang Zhong, Cen Xie, Pan Deng, Yifan Zhang, Xiaojian Dai, Xingxing Diao, Dafang Zhong, Zitao Guo, Kate Yu and Dongfeng Xue and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Science of The Total Environment.

In The Last Decade

Xiaoyan Chen

214 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyan Chen China 35 1.4k 801 693 654 551 222 4.4k
Hye Suk Lee South Korea 39 2.4k 1.7× 935 1.2× 529 0.8× 676 1.0× 415 0.8× 254 5.1k
Dion R. Brocks Canada 37 1.0k 0.7× 844 1.1× 790 1.1× 830 1.3× 527 1.0× 139 4.3k
Dafang Zhong China 36 1.8k 1.3× 1.1k 1.4× 913 1.3× 1.2k 1.8× 892 1.6× 266 5.2k
Arik Dahan Israel 48 1.3k 0.9× 647 0.8× 1.9k 2.7× 580 0.9× 797 1.4× 135 6.6k
Jingkai Gu China 31 1.1k 0.8× 417 0.5× 279 0.4× 498 0.8× 577 1.0× 202 3.5k
Fei Li China 46 3.1k 2.2× 1.1k 1.4× 1.3k 1.9× 425 0.6× 376 0.7× 226 7.1k
Yong Liu China 44 3.1k 2.2× 955 1.2× 710 1.0× 752 1.1× 303 0.5× 341 7.1k
Nariyasu Mano Japan 31 1.4k 1.0× 428 0.5× 1.2k 1.7× 312 0.5× 589 1.1× 300 4.2k
Sicen Wang China 38 2.1k 1.5× 640 0.8× 285 0.4× 387 0.6× 780 1.4× 210 4.8k
Zhong Zuo Hong Kong 47 3.4k 2.4× 1.8k 2.2× 909 1.3× 1.7k 2.5× 295 0.5× 247 8.5k

Countries citing papers authored by Xiaoyan Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Chen more than expected).

Fields of papers citing papers by Xiaoyan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Chen. The network helps show where Xiaoyan Chen may publish in the future.

Co-authorship network of co-authors of Xiaoyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Chen. A scholar is included among the top collaborators of Xiaoyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Chen. Xiaoyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jian, Yuhan Wang, Cuiping Zhang, et al.. (2025). Targeting PARK7: Sodium 4-Phenylbutyrate shields endothelial cells from oxidative stress and GSDME-mediated Pyroptosis in acute lung injury. International Immunopharmacology. 164. 115386–115386. 1 indexed citations
2.
3.
4.
Chen, Lin, et al.. (2025). Infertility management in resistant ovary syndrome: a review. Frontiers in Endocrinology. 16. 1560981–1560981. 1 indexed citations
5.
Zhou, Dan, Xiaoyan Chen, Yi Huang, et al.. (2024). The trigger mechanisms and the gene regulatory pathways of organic acid secretion during the vanadium-titanium magnetite tailing bioleaching. Journal of Hazardous Materials. 485. 136883–136883. 1 indexed citations
6.
Zhu, Huijuan, Qichen Ding, Xin Xu, et al.. (2023). Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects. Clinical and Translational Science. 16(5). 810–822. 5 indexed citations
7.
Zhang, Yu, Wen Wang, Miaojia Song, et al.. (2020). Kinetic study of lipase-catalyzed esterification of furoic acid to methyl-2-furoate. Biochemical Engineering Journal. 161. 107587–107587. 19 indexed citations
8.
Wang, Qingfeng, Wen Wang, Zahoor Zahoor, et al.. (2020). Recycling of Black Liquor for Treating Sugarcane Bagasse at Low Temperature to Attain High Ethanol Production without Washing Step. ACS Sustainable Chemistry & Engineering. 8(46). 17016–17021. 16 indexed citations
9.
Chen, Xiaoyan, Iva Dolinová, Alena Ševců, et al.. (2020). Strategies adopted by Aphanizomenon flos-aquae in response to phosphorus deficiency and their role on growth. Environmental Sciences Europe. 32(1). 9 indexed citations
10.
Feng, Hongxuan, Hongguang Zhang, Wei Wang, et al.. (2020). Development of Novel N-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents. Journal of Medicinal Chemistry. 63(3). 1051–1067. 18 indexed citations
11.
Xu, Wenjie, Ying Xiao, Xiaoyan Chen, et al.. (2020). Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor. Biomedicine & Pharmacotherapy. 129. 110410–110410. 8 indexed citations
12.
Chen, Xiaoyan, Congting Sun, Sixin Wu, & Dongfeng Xue. (2017). Nucleation-dependant chemical bonding paradigm: the effect of rare earth ions on the nucleation of urea in aqueous solution. Physical Chemistry Chemical Physics. 19(13). 8835–8842. 16 indexed citations
13.
Li, Xiuli, et al.. (2015). Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury. Drug Metabolism and Disposition. 43(11). 1751–1759. 77 indexed citations
14.
Lu, Youming, et al.. (2014). A sensitive LC–MS/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells. Journal of Chromatography B. 964. 202–207. 7 indexed citations
15.
Yang, Yong, Ke Liu, Dafang Zhong, & Xiaoyan Chen. (2012). Simultaneous determination of flumatinib and its two major metabolites in plasma of chronic myelogenous leukemia patients by liquid chromatography–tandem mass spectrometry. Journal of Chromatography A.
16.
Zhong, Dafang, et al.. (2011). Quantitative Analysis and Metabolite Identification of Therapeutic Oligonucleotides in Biological Samples Using LC/MS. 32(1). 13. 1 indexed citations
17.
Chen, Xiaoyan. (2011). Applications of Liquid Chromatography-Tandem Mass Spectrometry to Detection and Characterization of Reactive Metabolites. 1 indexed citations
18.
Zhang, Xiangrong, Meijuan Zou, Sanming Li, Xiaoyan Chen, & Dafang Zhong. (2008). Bioavailability of Clarithromycin Cyclodextrin Ternary Complexes Upon Oral Administration to Healthy Beagle Dogs. Drug Development and Industrial Pharmacy. 34(10). 1048–1053. 10 indexed citations
19.
Qiu, Feng, Xiaoyan Chen, Bo Song, Dafang Zhong, & Changxiao Liu. (2005). Influence of dosage forms on pharmacokinetics of daidzein and its main metabolite daidzein-7-O-glucuronide in rats1. Acta Pharmacologica Sinica. 26(9). 1145–1152. 37 indexed citations
20.
Chen, Xiaoyan, et al.. (2003). Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects.. PubMed. 24(7). 715–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hye Suk Lee Breakdown of academic impact, for papers by Dion R. Brocks Breakdown of academic impact, for papers by Dafang Zhong Breakdown of academic impact, for papers by Arik Dahan Breakdown of academic impact, for papers by Jingkai Gu Breakdown of academic impact, for papers by Fei Li Breakdown of academic impact, for papers by Yong Liu Breakdown of academic impact, for papers by Nariyasu Mano Breakdown of academic impact, for papers by Sicen Wang Breakdown of academic impact, for papers by Zhong Zuo
Rankless by CCL
2026